Skip to content
TNDMTandem Diabetes Care Inc

Earnings

When Tandem Diabetes Care Inc reports, what it reported each quarter, and how the stock took the results.

55 quarters. Mar 31, 2013 to Sep 30, 2026. USD.

Next results · Q4 2026Projected

Feb 18, after the close

Thu, Feb 18, 2027in 93 days

Projected from its last 8 releases. The company has not named the day yet.

Quarter
Q4 2026 · Ends about Dec 31, 2026
10-K window
Feb 18 – Mar 1

Read against Q4 2025

The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.

Revenue
$290.38M
Revenue, change from a year earlier: Q3 2026 +13.8%, Q2 2026 +5.8%, Q1 2026 +5.5%, Q4 2025 +2.7%
Net income
-$589.00K
Net income, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m
EPS
-$0.01
EPS, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m

Quarter by quarter

Q3 2026$283.69M+13.8% vs Q3 2025

Latest results

  1. Q3 2026Nov 5, 2026, after the closeThe release5.4%by the close of Nov 6
    Revenue
    $283.69M
    +13.8%
    Net income
    -$7.09M
    N/M
    EPS
    -$0.10
    N/M
  2. Q2 2026Aug 6, 2026, after the closeThe release+19.2%by the close of Aug 7
    Revenue
    $254.56M
    +5.8%
    Net income
    -$21.17M
    N/M
    EPS
    -$0.31
    N/M
  3. Q1 2026May 7, 2026, after the closeThe release16.3%by the close of May 8
    Revenue
    $247.22M
    +5.5%
    Net income
    -$20.39M
    N/M
    EPS
    -$0.30
    N/M
  4. Q4 2025Feb 19, 2026, after the closeThe release+32.6%by the close of Feb 20
    Revenue
    $290.38M
    +2.7%
    Net income
    -$589.00K
    N/M
    EPS
    -$0.01
    N/M

All quarters

PeriodEndedAnnouncedFiledLagFormRevenueΔ yoyEPS dil.MoveSource trail
FY 2026
Q3 2026Sep 30, 2026Nov 5, 2026 · after-hoursNov 5, 202636 d10-Q$283.69M+13.8%-$0.105.4%
Q2 2026Jun 30, 2026Aug 6, 2026 · after-hoursAug 6, 202637 d10-Q$254.56M+5.8%-$0.31+19.2%
Q1 2026Mar 31, 2026May 7, 2026 · after-hoursMay 7, 202637 d10-Q$247.22M+5.5%-$0.3016.3%
FY 2025
Q4 2025Dec 31, 2025Feb 19, 2026 · after-hoursFeb 19, 202650 d10-K$290.38M+2.7%-$0.01+32.6%
Q3 2025Sep 30, 2025Nov 6, 2025 · after-hoursNov 6, 202537 d10-Q$249.25M+2.2%-$0.31+22.0%
Q2 2025Jun 30, 2025Aug 6, 2025 · after-hoursAug 6, 202537 d10-Q$240.68M+8.5%-$0.7819.8%
Q1 2025Mar 31, 2025Apr 30, 2025 · after-hoursApr 30, 202530 d10-Q$234.42M+22.3%-$1.97+18.5%
FY 2024
Q4 2024Dec 31, 2024Feb 26, 2025 · after-hoursFeb 26, 202557 d10-K$282.65M+43.6%$0.0135.2%
Q3 2024Sep 30, 2024Nov 6, 2024 · after-hoursNov 6, 202437 d10-Q$243.97M+31.4%-$0.352.7%
Q2 2024Jun 30, 2024Aug 1, 2024 · after-hoursAug 1, 202432 d10-Q$221.91M+13.3%-$0.47+18.3%
Q1 2024Mar 31, 2024May 2, 2024 · after-hoursMay 2, 202432 d10-Q$191.67M+13.2%-$0.65—
Earlier years, FY 2013 to FY 2023

Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Source filings

10-QNov 5, 2026000144
10-QAug 6, 2026000125
10-QMay 7, 2026000049
10-KFeb 19, 2026000010
10-QNov 6, 2025000187
10-QAug 6, 2025000157
10-QApr 30, 2025000069
10-KFeb 26, 2025000036
10-QNov 6, 2024000201
10-QAug 1, 2024000177

Provenance

ProvenanceData status and checks

Tandem Diabetes Care Inc · CIK 1438133 · Engraved from SEC EDGAR